Gilead’s Coronavirus Drug Success Spurs Biotech Stocks to Outperform

(Bloomberg) -- Gilead Sciences Inc.’s pair of promising announcements for its Covid-19 drug candidate, remdesivir, sparked a further rally in biotechnology stocks that have already been on a tear o...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.